Two different perspectives in the management of pT3 and/or margin-positive prostate cancer after radical prostatectomy.
Choo
Richard
R
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA. choo.c@mayo.edu
Kawakami
Jun
J
Siemens
Robert
R
Davis
Brian J
BJ
Brundage
Michael
M
Pisansky
Thomas M
TM
D000368:Aged; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
D017430:Prostate-Specific Antigen